The world’s only searchable, sortable database of stem cell therapy companies that is publicly available.
Today, there are nearly 250 companies worldwide that are developing stem cell products for therapeutic use in humans to address a diverse range of chronic and acute conditions.
Currently, mesenchymal stem cells / medicinal signaling cells (MSCs) and hematopoietic stem cells are the most commonly used stem cell types. However, induced pluripotent stem cells (iPSCs) are also gaining traction, with dozens of companies now forging the path toward iPSC-derived cellular therapeutics.
Other stem cell types, such as neural stem cells and embryonic stem cells, are being used more selectively. Of course, stem cell derived exosomes have rapidly expanded their therapeutics applications in recent years too.
The rapid growth of stem cell companies is being driven by:
- Accelerated funding for stem cell therapies
- Increased interest among pharmaceutical companies in stem cell partnerships
- Investor appetite for stem cell based therapeutics
- Use of cell therapies in the treatment of COVID-19 complications, such as immune and respiratory complications
- Rising numbers of stem cell therapy trials underway worldwide
Stem Cell Therapy Companies
This comprehensive database of stem cell companies includes all known market competitors who are developing stem cell therapies for use in human patients.
For each entry, it includes the following data points:
- Company Name
- Location (City/State)
- Description of Stem Cell Therapy/Technology
- Contact Email
- Company LinkedIn Page
Because this database is an essential resource within our company, we are confident it will be a valuable resource for you too. It was originally developed in-house for our own purposes, but we have had many clients requesting access to it.
When you check out below, your product will be delivered instantly as an Excel download. Of course, your investment is backed by a Greater than 100% Money Back Guarantee.